See more : Piramal Enterprises Limited (PEL.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Krishna Institute of Medical Sciences Limited (KIMS.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Krishna Institute of Medical Sciences Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Huangshan Novel Co.,Ltd (002014.SZ) Income Statement Analysis – Financial Results
- Admiral Group plc (AMIGF) Income Statement Analysis – Financial Results
- Fuva Brain Limited (3927.T) Income Statement Analysis – Financial Results
- Pets at Home Group Plc (PETS.L) Income Statement Analysis – Financial Results
- Chang Jiang Shipping Group Phoenix Co.,Ltd (000520.SZ) Income Statement Analysis – Financial Results
Krishna Institute of Medical Sciences Limited (KIMS.BO)
About Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand name in India. The company offers range of specialties, including cardiac, dental, neuro, oncological, orthopedic, renal, reproductive, and robotic sciences, as well as gastroenterology and hepatology, heart and lung transplant, organ transplantation, mother and childcare, and pediatrics services. It also focuses on accident, biochemistry, anesthesiology, bariatric surgery, andrology and infertility, arthroscopy, alzheimers, bone, joint center specialties, and others. The company was incorporated in 1973 and is based in Secunderabad, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 24.98B | 21.98B | 16.51B | 13.12B | 11.23B | 9.18B | 6.64B | 5.67B | 5.12B | 4.22B | 3.57B | 2.94B |
| Cost of Revenue | 17.61B | 8.27B | 6.17B | 4.93B | 4.52B | 3.73B | 4.98B | 4.59B | 4.10B | 1.97B | 3.38B | 2.63B |
| Gross Profit | 7.37B | 13.71B | 10.34B | 8.19B | 6.70B | 5.45B | 1.65B | 1.08B | 1.02B | 2.26B | 193.65M | 309.50M |
| Gross Profit Ratio | 29.52% | 62.37% | 62.62% | 62.42% | 59.72% | 59.34% | 24.92% | 19.11% | 19.86% | 53.45% | 5.43% | 10.52% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 243.16M | 1.75B | 3.10B | 2.72B | 2.56B | 2.16B | 500.33M | 144.78M | 140.91M | 1.28B | 0.00 | 0.00 |
| Selling & Marketing | 251.59M | 197.39M | 111.51M | 91.81M | 113.01M | 106.62M | 65.94M | 57.29M | 65.94M | 22.99M | 0.00 | 0.00 |
| SG&A | 494.75M | 1.95B | 3.21B | 2.81B | 2.68B | 2.27B | 566.27M | 202.07M | 206.85M | 1.31B | 34.63M | 32.82M |
| Other Expenses | 9.30B | 258.72M | 202.60M | 36.14M | 43.66M | 31.21M | -72.74M | -41.37M | -41.66M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 494.75M | 8.96B | 5.91B | 5.06B | 4.85B | 4.04B | 639.01M | 243.44M | 248.51M | 1.81B | 20.78M | 25.31M |
| Cost & Expenses | 19.88B | 17.23B | 12.08B | 9.99B | 9.37B | 7.78B | 5.62B | 4.83B | 4.35B | 3.78B | 3.40B | 2.66B |
| Interest Income | 18.74M | 61.09M | 122.82M | 57.99M | 12.63M | 5.84M | 2.10M | 6.62M | 14.33M | 313.24M | 0.00 | 0.00 |
| Interest Expense | 545.74M | 305.45M | 160.33M | 293.15M | 387.51M | 447.04M | 881.45M | 325.00M | 370.62M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 1.47B | 1.29B | 726.73M | 695.36M | 706.11M | 564.56M | 400.68M | 351.34M | 354.98M | 321.68M | 246.90M | 209.57M |
| EBITDA | 6.53B | 6.51B | 5.42B | 3.86B | 2.56B | 904.71M | 1.07B | 1.20B | 1.13B | 800.45M | 405.92M | 637.81M |
| EBITDA Ratio | 26.12% | 28.66% | 33.05% | 29.24% | 22.84% | 21.34% | 21.33% | 21.01% | 21.94% | 18.96% | 11.37% | 16.52% |
| Operating Income | 5.04B | 4.89B | 4.56B | 3.13B | 1.87B | 1.17B | 1.01B | 840.24M | 767.83M | 478.77M | 159.02M | 276.68M |
| Operating Income Ratio | 20.19% | 22.24% | 27.61% | 23.88% | 16.65% | 12.70% | 15.29% | 14.82% | 15.00% | 11.34% | 4.46% | 9.40% |
| Total Other Income/Expenses | -446.75M | -7.98B | -5.06B | -4.79B | -406.25M | -1.38B | -1.23B | -312.40M | -358.81M | -336.98M | 13.85M | 7.51M |
| Income Before Tax | 4.60B | 4.85B | 4.57B | 2.79B | 1.41B | -153.81M | -213.44M | 527.84M | 409.02M | 132.92M | 172.87M | 284.19M |
| Income Before Tax Ratio | 18.40% | 22.06% | 27.67% | 21.26% | 12.52% | -1.68% | -3.22% | 9.31% | 7.99% | 3.15% | 4.84% | 9.66% |
| Income Tax Expense | 1.24B | 1.19B | 1.13B | 735.36M | 254.54M | 334.26M | 257.40M | 192.99M | 129.28M | 69.29M | 103.29M | 95.37M |
| Net Income | 3.10B | 3.36B | 3.33B | 2.01B | 1.19B | -477.69M | -473.55M | 325.56M | 266.15M | 56.08M | 69.47M | 188.82M |
| Net Income Ratio | 12.42% | 15.30% | 20.15% | 15.33% | 10.62% | -5.20% | -7.14% | 5.74% | 5.20% | 1.33% | 1.95% | 6.42% |
| EPS | 7.75 | 42.03 | 41.88 | 26.88 | 16.00 | -5.97 | -9.44 | 4.61 | 3.78 | 0.80 | 0.99 | 2.69 |
| EPS Diluted | 7.75 | 42.03 | 41.88 | 26.42 | 15.87 | -5.97 | -9.44 | 4.61 | 3.78 | 0.80 | 0.99 | 2.69 |
| Weighted Avg Shares Out | 400.14M | 80.03M | 79.44M | 74.87M | 74.49M | 80.03M | 50.15M | 70.66M | 70.40M | 70.33M | 69.91M | 70.22M |
| Weighted Avg Shares Out (Dil) | 400.14M | 80.03M | 79.44M | 76.15M | 75.08M | 80.03M | 50.15M | 70.66M | 70.40M | 70.33M | 69.84M | 70.15M |
Source: https://incomestatements.info
Category: Stock Reports